Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Invest Dermatol. 2019 Apr 5;139(9):1898–1905.e2. doi: 10.1016/j.jid.2019.02.033

Figure 2 – Risk perception, self-efficacy, and performance of SSE and PSE.

Figure 2 –

Adjusted for sex, education, age (years), race/ethnicity, skin type, age at diagnosis, diagnosis, chemotherapy (yes/no), Highest CTCAE Grade Chronic Condition maximum radiotherapy dose patient activation